指南与共识重症综合管理与镇静镇痛消化、代谢与肾脏急症

危重急性肾损伤患者肾脏替代治疗强度与结局:对剂量推荐的批判性评价

Intensity of renal replacement therapy and outcomes in critically ill patients with acute kidney injury: Critical appraisal of the dosing recommendations.
指南 / 共识 · Ther Apher Dial · 2020-02-08
一句话结论KDIGO的RRT剂量推荐缺乏弹性且可能部分过时;高剂量CRRT可能对某些重症AKI亚组带来生存获益,但可致血流动力学、电解质、营养与抗菌药剂量等临床相关不良影响。

本文批判性评价了危重急性肾损伤需透析(AKI-D)患者肾脏替代治疗(RRT)的剂量推荐。作者指出,间歇或连续RRT的最佳剂量及最小或最大有效剂量均未知,KDIGO AKI指南的RRT剂量推荐缺乏弹性、基于有限研究且可能至少部分过时。高强度治疗可能与全身及肾脏血流动力学改变、严重电解质失衡、营养素或热能丢失及抗菌药物剂量不足相关;但较高剂量连续肾脏替代治疗(CRRT)可能对某些重症AKI重症监护亚组带来生存获益。低于推荐充分剂量的CRRT剂量可能不会导致不良健康结局,至少在亚洲患者中如此。未来研究应评估需求-容量概念,并开展大规模研究评价精准RRT剂量调整能否改善重症患者亚组的以患者为中心的结局。

要点

  • KDIGO AKI指南的RRT剂量推荐缺乏弹性、基于有限研究且可能至少部分过时。
  • 间歇或连续RRT的最佳剂量及最小或最大有效剂量均未知。
  • 高强度治疗可能与全身及肾脏血流动力学改变、严重电解质失衡、营养素或热能丢失及抗菌药物剂量不足相关。
  • 较高剂量CRRT可能对某些重症AKI重症监护亚组带来生存获益。
  • 低于推荐充分剂量的CRRT剂量可能不会导致不良健康结局,至少在亚洲患者中如此。

适用人群与场景

  • 危重急性肾损伤需透析(AKI-D)患者。
  • 重症监护中需要肾脏替代治疗的重症AKI患者。

研究设计与关键结果

  • 本文为对KDIGO AKI指南RRT剂量推荐的批判性评价,指出间歇或连续RRT的最佳剂量及最小或最大有效剂量均未知。
  • KDIGO AKI指南的RRT剂量推荐缺乏弹性、基于有限研究且可能至少部分过时。
  • 高强度治疗可能与全身及肾脏血流动力学改变、严重电解质失衡、营养素或热能丢失及抗菌药物剂量不足相关。
  • 较高剂量CRRT可能对某些重症AKI重症监护亚组带来生存获益。
  • 低于推荐充分剂量的CRRT剂量可能不会导致不良健康结局,至少在亚洲患者中如此。

证据类型、等级与局限

  • 证据类型:对KDIGO AKI指南RRT剂量推荐的批判性评价。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,未来研究应评估需求-容量概念,认识到RRT剂量的实施是动态的,并应根据患者相关因素进行调整。
  • 作者认为,需要大规模研究评价精准RRT剂量调整能否改善重症患者亚组的以患者为中心的结局。

指南或共识出处

  • KDIGO AKI指南

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The current care of critically ill patients with severe acute kidney injury requiring dialysis (AKI-D) is limited to supportive management in which renal replacement therapy (RRT) plays a central role. Renal replacement techniques are invasive bioincompatible procedures and are therefore associated with complications that may prove harmful to fragile patients. Inexperience with the standards and lacking or misinterpreted recommendations for the delivery of the RRT dose increases the risk of serious complications. Neither the optimal doses of intermittent or continuous RRTs nor the minimal or maximal effective doses are known. The Kidney Disease Improving Global outcomes (KDIGO) AKI guidelines for RRT dosing recommendations are inflexible, based on limited research, and may be at least partially outdated. High-intensity therapy may be associated with clinically relevant alterations in systemic and renal hemodynamics, profound electrolyte imbalances, the loss of nutrients or thermal energy, and underdosing of antimicrobial agents. However, higher doses of continuous renal replacement therapy (CRRT) may confer a survival benefit for certain subgroups of intensive care patients with severe AKI. Lower CRRT doses than the recommended adequate dosage may not lead to negative health outcomes, at least in Asian patients. Future research should evaluate the demand-capacity concept, recognizing that the delivery of the RRT dose is dynamic and should be modified in response to patient-related factors. There is a need for large-scale studies evaluating whether precision RRT dose modifications may improve patient-centered outcomes in subgroups of critically ill patients.

来源:Ther Apher Dial,查看原文。版权归原作者所有。

参考来源

  1. Schiffl H. Intensity of renal replacement therapy and outcomes in critically ill patients with acute kidney injury: Critical appraisal of the dosing recommendations. Ther Apher Dial. 2020. PMID: 31904909. doi:10.1111/1744-9987.13471

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。